New York, New York, United States Swiss Helvetia Fund is the famous VC, which was founded in 1986. The fund was located in North America if to be more exact in United States. The main office of represented VC is situated in the New York.
Besides them, we counted 2 critical employees of this fund in our database.
For fund there is no match between the country of its foundation and the country of its the most frequent investments - Switzerland. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. We can highlight the next thriving fund investment areas, such as Mineral, Biotechnology. Among the most popular portfolio startups of the fund, we may highlight Kuros Biosciences, Synosia Therapeutics.
The standard case for the fund is to invest in rounds with 5 partakers. Despite the Swiss Helvetia Fund, startups are often financed by Versant Ventures, VI Partners AG, VINCI CAPITAL. The meaningful sponsors for the fund in investment in the same round are Versant Ventures, Investor Growth Capital Limited, Aravis Ventures. In the next rounds fund is usually obtained by Versant Ventures, UCB Pharma, Novo Holdings.
Speaking about the real fund results, this VC is 5 percentage points more often commits exit comparing to other organizations. The top amount of exits for fund were in 2016. The fund is generally included in less than 2 deals every year. The top activity for fund was in 2015. Comparing to the other companies, this Swiss Helvetia Fund performs on 21 percentage points more the average number of lead investments. Deals in the range of 10 - 50 millions dollars are the general things for fund.
Related Funds
Funds with similar focus
| Fund Name | Location |
| Axiometrics | Dallas, Texas, United States |
| Bayfront Capital Partners, Ltd. | - |
| Blackstone Alternative Asset Management | New York, New York, United States |
| Fairchild Capital Management | China, Hong Kong, Hong Kong Island |
| Guorui Investment | China, Jinshan District |
| ID Capital | Central, Central Region, Singapore |
| Liushi Venture Capital | Beijing, Beijing, China |
| Lovett Miller & Co. | Florida, Jacksonville, United States |
| M Krishna Sindhuri Private Trust | - |
| Mivtach Shamir Holdings LTD | Israel, Tel Aviv, Tel Aviv District |
| MTN | Gauteng, Johannesburg, South Africa |
| SIP (Strategic Investment Partners Ltd.) | England, London, United Kingdom |
| Source-Israel | Hefa, Israel, Tirat Carmel |
| Status.im | Switzerland, Zug, Zug |
| SternAegis Ventures | New York, New York, United States |
| Sunhope Capital | California, San Jose, United States |
| Sydes | - |
| Virtus Nutrition | California, Corcoran, United States |
| Xingniu Touzi | China, Wenzhou, Zhejiang |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Selfrag | $9M | 09 Jan 2012 | Fribourg, Switzerland | ||
Synosia Therapeutics | $30M | 12 Oct 2010 | Basel, Basel-City, Switzerland | ||
Synosia Therapeutics | $29M | 01 Jan 2009 | Basel, Basel-City, Switzerland |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Selfrag | $9M | 09 Jan 2012 | Fribourg, Switzerland | ||
Synosia Therapeutics | $30M | 12 Oct 2010 | Basel, Basel-City, Switzerland | ||
Synosia Therapeutics | $29M | 01 Jan 2009 | Basel, Basel-City, Switzerland |
